Company:  BIOPHYTIS SA
Form Type:  F-1/A
Filing Date:  7/11/2019 
CIK:  0001768946 
Address:  SORBONNE UNIVERSITY, BC 9
BATIMENT A 4EME ETAGE, 4 PLACE JUSSIEU
 
City, State, Zip:  PARIS,  75001 
Telephone:  33 1 44 37 23 00 
Description of Business
We are a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Our goal is to become a leader in the emerging field of aging science by delivering life-changing therapies to the growing number of patients in need. To accomplish this goal, we have assembled an experienced and skilled group of industry professionals, scientists, clinicians and key opinion leaders from leading industry and academic institutions from around the world. A number of degenerative diseases associated with aging have been characterized in the last century, including sarcopenia and AMD. The pathophysiology of these and many other age-related diseases is not yet well understood, and effective treatment solutions are lacking.
Register and access this filing in:     
  FORM F-1/A
    CALCULATION OF REGISTRATION FEE
    Subject to Completion, dated July 11, 2019
    TABLE OF CONTENTS
    PROSPECTUS SUMMARY
    The Global Offering
    Summary Consolidated Financial Data
      BALANCE SHEET
    RISK FACTORS
    SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
    USE OF PROCEEDS
    DIVIDEND POLICY
    CAPITALIZATION
    DILUTION
      BENEFICIAL OWNERS
    SELECTED FINANCIAL AND OTHER DATA
      BALANCE SHEET
    MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
      Liquidity and Capital Resources
      Quantitative and Qualitative Disclosures About Market Risk
    BUSINESS
      Competition
      Employees
      Legal Proceedings
    MANAGEMENT
      NAME AND TITLE
      NAME AND TITLE
    Compensation of Directors and Executive Officers
    Director Compensation
    RELATED PARTY TRANSACTIONS
    PRINCIPAL SHAREHOLDERS
      BENEFICIAL OWNERS
    DESCRIPTION OF SHARE CAPITAL AND ARTICLES OF ASSOCIATION
    Transfer Agent and Registrar
    DESCRIPTION OF AMERICAN DEPOSITARY SHARES
    Tender and Exchange Offers; Redemption, Replacement or ...
    SHARES AND ADSs ELIGIBLE FOR FUTURE SALE
    MATERIAL UNITED STATES FEDERAL INCOME TAX AND FRENCH TAX ...
    ENFORCEMENT OF CIVIL LIABILITIES
    UNDERWRITING
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND MORE INFORMATION
    Index to the Financial Statements
      REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
      NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
        BALANCE SHEET
        BALANCE SHEET
        STOCKHOLDERS EQUITY
        CASH FLOW
        BALANCE SHEET
        BALANCE SHEET
    PART II
      Item 6. Indemnification of Directors and Officers
      Item 7. Recent Sales of Unregistered Securities
      Item 8. Exhibits
      Item 9. Undertakings
    SIGNATURES
  EXHIBIT 5.1
  EXHIBIT 23.1
    Consent of Independent Registered Public Accounting Firm